Neogen stock touches 52-week low at $7.93 amid market challenges

Published 04/04/2025, 14:56
Neogen stock touches 52-week low at $7.93 amid market challenges

Neogen Corporation’s stock has faced significant headwinds, touching a 52-week low of $7.93, with the current price of $7.80 representing a 58% decline from its 52-week high of $18.58. According to InvestingPro analysis, the stock is currently trading near its Fair Value. This price level reflects a stark contrast to the company’s performance over the past year, with Neogen Corp (NASDAQ:NEOG) experiencing a substantial 1-year change, plummeting by -45.78%. While the company maintains strong liquidity with a current ratio of 3.77, InvestingPro data reveals the company isn’t currently profitable. However, analysts expect a return to profitability this year, with projected earnings of $0.43 per share. The current low serves as a critical point of interest for both potential buyers looking for a bargain and existing shareholders concerned about the stock’s trajectory. For deeper insights, investors can access 8 additional key ProTips and a comprehensive Pro Research Report covering Neogen’s financial health and growth prospects.

In other recent news, Neogen Corporation announced its second-quarter financial results, reporting a modest revenue increase to $231.3 million, up 0.7% from the previous year. Despite this growth, the company faced a net loss of $456.3 million due to a non-cash goodwill impairment charge related to its acquisition of 3M’s Food Safety Division. Excluding this charge, the adjusted net income was $24.4 million, or $0.11 per diluted share. Neogen’s Food Safety segment saw a slight revenue decline of 0.1%, while the Animal Safety segment experienced a 2.8% increase. In other developments, Neogen introduced a new Salmonella detection kit for the poultry industry, enhancing its pathogen testing capabilities. The company also resolved a labor practices claim by the National Labor Relations Board, paving the way for a unionization vote among its employees. Additionally, Neogen’s stock was downgraded by Piper Sandler, reflecting investor concerns despite the company’s efforts to strengthen its product offerings and market presence.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.